Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 301 - 400
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 301 | 26519287 |
2 | ||
Nasopharyngitis, Dehydration, Vomiting, Diarrhoea, Rash, Dyspnoea, Blood creatinine increased, Malignant neoplasm of spinal cord, |
||||
RIBOCICLIB, FULVESTRANT, CAPIVASERTIB, |
||||
| 302 | 26507704 |
CA |
58 | 2 |
Abdominal discomfort, Back injury, Benign abdominal neoplasm, Benign ovarian tumour, Blood pressure diastolic abnormal, Blood pressure increased, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Body temperature decreased, Chills, Drug hypersensitivity, Fungal infection, Gait disturbance, Human papilloma virus test positive, Impaired healing, Infection, Influenza, Lip injury, Lower respiratory tract congestion, Migraine, Musculoskeletal stiffness, Nasopharyngitis, Oral herpes, Oral herpes, Oral herpes, Oral herpes, Oral pain, Oropharyngeal pain, Ovarian cyst, Oxygen saturation decreased, Pneumonia, Productive cough, Rheumatoid arthritis, Rhinorrhoea, Skin fissures, Sneezing, Stomatitis, Stomatitis, Tinnitus, Ulcer, Upper respiratory tract infection, Drug interaction, Back pain, Malaise, Gastrooesophageal reflux disease, Cough, Hepatic enzyme increased, Infusion related reaction, Nausea, Nausea, Pain, Paraesthesia, Weight decreased, Weight increased, Arthralgia, Drug ineffective, |
||||
PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FOLIC ACID, HYDROXYCHLOROQUINE SULFATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, |
||||
| 303 | 26507748 |
CA |
29 | |
Oropharyngeal pain, Aphonia, Cough, Wisdom teeth removal, Condition aggravated, Clostridium difficile infection, Nasopharyngitis, Urinary tract infection, COVID-19, Fatigue, Therapeutic response shortened, Maternal exposure timing unspecified, Intentional product use issue, Off label use, Off label use, Overdose, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 304 | 26507769 |
US |
63 | 1 |
Nasopharyngitis, Product container seal issue, Product quality issue, Anxiety, |
||||
TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 305 | 26507790 |
CN |
74 | 1 |
Nasopharyngitis, Chronic obstructive pulmonary disease, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 306 | 26507907 |
US |
75 | 2 |
Nasopharyngitis, Flatulence, Secretion discharge, Infection, Central obesity, |
||||
EVOLOCUMAB, |
||||
| 307 | 26507917 |
|||
Psoriasis, Onychoclasis, Upper respiratory tract infection, Nasopharyngitis, |
||||
BIMEKIZUMAB, EZETIMIBE, LISINOPRIL, ROSUVASTATIN CALCIUM, |
||||
| 308 | 26507961 |
US |
2 | |
Nasopharyngitis, Cough, |
||||
DIMETHYL FUMARATE, DIMETHYL FUMARATE, |
||||
| 309 | 26508150 |
US |
78 | 2 |
Pneumonia, Cough, Nasopharyngitis, Therapy interrupted, |
||||
VIBEGRON, |
||||
| 310 | 26508278 |
US |
25 | 1 |
Prescribed underdose, Nasopharyngitis, |
||||
NATALIZUMAB, |
||||
| 311 | 26508481 |
US |
12 | 2 |
Nasopharyngitis, |
||||
NUSINERSEN, |
||||
| 312 | 26508711 |
US |
2 | |
Neuropathy peripheral, Autoimmune disorder, Gingival disorder, Nasopharyngitis, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 313 | 26508979 |
CA |
58 | 2 |
Arthralgia, Hypoaesthesia, Urinary tract infection, Carpal tunnel syndrome, Off label use, Musculoskeletal stiffness, Dupuytren^s contracture, Skin laceration, Nasopharyngitis, |
||||
OCRELIZUMAB, |
||||
| 314 | 26509508 |
EU |
73 | 1 |
Pneumonia, Underdose, Contraindicated product administered, Hypokinesia, Device use error, Weight decreased, Nasopharyngitis, Decubitus ulcer, Secretion discharge, Akinesia, Dyskinesia, Asthenia, Weight decreased, Hyperkinesia, Psychomotor hyperactivity, Somnolence, Dysarthria, General physical health deterioration, Incorrect dose administered, Device issue, Psychomotor hyperactivity, |
||||
CLINDAMYCIN HYDROCHLORIDE, OXAZEPAM, OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, PREGABALIN, ROTIGOTINE, DARIFENACIN HYDROBROMIDE, PANTOPRAZOLE, MAGNESIUM, OXYCODONE, MIRTAZAPINE, AMANTADINE, SERTRALINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SIMVASTATIN, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, AMLODIPINE, CANDESARTAN, |
||||
| 315 | 26509555 |
CN |
38 | 2 |
Nasopharyngitis, Cough, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 316 | 26509618 |
US |
||
Nasopharyngitis, Adverse drug reaction, Cough, Oropharyngeal pain, |
||||
| 317 | 26509753 |
US |
94 | 2 |
Nasopharyngitis, |
||||
PIMAVANSERIN TARTRATE, LORAZEPAM, FAMOTIDINE, PROPRANOLOL HYDROCHLORIDE, AMLODIPINE, ALBUTEROL SULFATE, LISINOPRIL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, PSYLLIUM HUSK, POLYETHYLENE GLYCOL 3350, CALCIUM CARBONATE, VITAMIN E, |
||||
| 318 | 26509900 |
US |
||
Nasopharyngitis, Flatulence, Central obesity, |
||||
EVOLOCUMAB, |
||||
| 319 | 26509904 |
US |
||
Nasopharyngitis, |
||||
TREPROSTINIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, POVIDONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, BUMETANIDE, CALCIUM, MACITENTAN, OXYGEN, 0XYGEN, SILDENAFIL CITRATE, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, |
||||
| 320 | 26509944 |
US |
||
Oropharyngeal pain, Cough, Nasopharyngitis, Nasal congestion, Myalgia, |
||||
TREPROSTINIL, EMPAGLIFLOZIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DICLOFENAC SODIUM, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM AND SENNOSIDES, DOCUSATE SODIUM SENNOSIDES, AMOXICILLIN AND CLAVULANATE POTASSIUM, ERGOCALCIFEROL, ALBUTEROL SULFATE, FAMOTIDINE, LIRAGLUTIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NINTEDANIB, SPIRONOLACTONE, OXYGEN, 0XYGEN, AZITHROMYCIN DIHYDRATE, NALTREXONE, BENZONATATE, IPRATROPIUM BROMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 321 | 26510231 |
US |
67 | 2 |
Productive cough, Dizziness, Vision blurred, Cough, Rhinorrhoea, Nausea, Chest pain, Chest discomfort, Nasopharyngitis, Sputum abnormal, Weight decreased, Abdominal discomfort, Decreased appetite, Heart rate increased, |
||||
NERANDOMILAST, |
||||
| 322 | 26510319 |
US |
69 | 2 |
Nasopharyngitis, Anxiety, Insomnia, Nausea, |
||||
TIRZEPATIDE, |
||||
| 323 | 26510420 |
US |
51 | 2 |
Nasopharyngitis, Heart rate decreased, |
||||
| 324 | 26510768 |
US |
||
Nasopharyngitis, |
||||
TESAMORELIN, |
||||
| 325 | 26511791 |
CA |
40 | 2 |
Abdominal distension, Arthralgia, Arthropathy, Back injury, Blepharospasm, Blister, Breast cancer stage III, Bursitis, Coeliac disease, Condition aggravated, Confusional state, Contusion, Depression, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lung disorder, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Wheezing, Wound, Wound infection, Abdominal pain upper, Alopecia, Asthenia, Diarrhoea, Lower respiratory tract infection, Hepatitis, Drug-induced liver injury, Hypotension, Malaise, Nausea, Pneumonia, Rash, Vomiting, Abdominal discomfort, |
||||
AZATHIOPRINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LAMOTRIGINE, LAMOTRIGINE, MEPOLIZUMAB, |
||||
| 326 | 26512112 |
CA |
27 | 2 |
Pneumonia bacterial, Nasopharyngitis, Influenza, |
||||
INFLIXIMAB, |
||||
| 327 | 26502775 |
US |
59 | 2 |
Systemic lupus erythematosus, Nasopharyngitis, Fatigue, Abdominal pain upper, Diarrhoea, Sinus disorder, Diarrhoea, Abdominal distension, Chronic active Epstein-Barr virus infection, Upper respiratory tract infection, Dyspnoea, |
||||
PANCRELIPASE, PANCRELIPASE, PANCRELIPASE, PANCRELIPASE, |
||||
| 328 | 26502826 |
US |
73 | 2 |
Urinary incontinence, COVID-19, Urinary tract infection, Urinary tract infection, Fungal infection, Upper respiratory tract infection, Visual impairment, Malaise, Nasopharyngitis, Urinary tract infection, Urinary tract infection, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, |
||||
| 329 | 26503165 |
CA |
17 | 1 |
Crohn^s disease, Drug level decreased, Nasopharyngitis, Illness, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 330 | 26503401 |
US |
2 | |
Nasopharyngitis, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 331 | 26503938 |
EU |
2 | |
Immunoglobulins decreased, Anal abscess, Nasopharyngitis, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, ERGOCALCIFEROL, |
||||
| 332 | 26504002 |
US |
||
Nasopharyngitis, Dyspnoea exertional, Fatigue, Tremor, Anxiety, Depression, Oedema peripheral, Constipation, Arthralgia, Incontinence, Fall, Pharyngitis streptococcal, Product dose omission issue, Cough, Chest pain, Diarrhoea, Oropharyngeal pain, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ACETAMINOPHEN, FUROSEMIDE, BIOTIN, LISINOPRIL, OXYGEN, 0XYGEN, PROPRANOLOL HYDROCHLORIDE, OXCARBAZEPINE, LACOSAMIDE, |
||||
| 333 | 26504036 |
US |
||
Nephrolithiasis, Blood urine present, Insomnia, Malaise, Asthenia, Suffocation feeling, Productive cough, Nasopharyngitis, Cough, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, SPIRONOLACTONE, RIFAXIMIN, LACTULOSE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TAMSULOSIN HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, GUAIFENESIN, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ZOLPIDEM TARTRATE, APREMILAST, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, BUSPIRONE HYDROCHLORIDE, OXYGEN, 0XYGEN, SOLIFENACIN SUCCINATE, MONTELUKAST SODIUM, MONTELUKAST, SITAGLIPTIN, LORATADINE, LORATADINE ORAL, URSODIOL, URSOSIOL, |
||||
| 334 | 26504049 |
US |
||
Epistaxis, Malaise, Nasopharyngitis, Fall, Nausea, Dizziness, Throat irritation, Cough, Oropharyngeal pain, |
||||
TREPROSTINIL, TREPROSTINIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MELATONIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ESOMEPRAZOLE MAGNESIUM, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, OXYGEN, 0XYGEN, FUROSEMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE, |
||||
| 335 | 26504058 |
US |
||
Gait disturbance, Drug intolerance, Pain in jaw, Nasopharyngitis, Influenza, Chest discomfort, Cough, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AMLODIPINE BESYLATE, EMPAGLIFLOZIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FINASTERIDE, BRINZOLAMIDE/BRIMONIDINE TARTRATE, NETARSUDIL, EPLERENONE, OXYGEN, 0XYGEN, LATANOPROST, PREDNISONE, |
||||
| 336 | 26504061 |
US |
||
Fatigue, Productive cough, Nasopharyngitis, Hot flush, Dyspnoea, Cough, Chest discomfort, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, FAMOTIDINE, RIOCIGUAT, CLONIDINE HYDROCHLORIDE, ACETAMINOPHEN, WARFARIN SODIUM, WARFARIN, ALLOPURINOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIOTROPIUM BROMIDE INHALATION SPRAY, OXYGEN, 0XYGEN, DOFETILIDE, AMLODIPINE BESYLATE, STANDARDIZED SENNA CONCENTRATE, ROSUVASTATIN CALCIUM, TORSEMIDE, |
||||
| 337 | 26504573 |
US |
14 | 1 |
Nasopharyngitis, Lower respiratory tract congestion, Memory impairment, Pyrexia, |
||||
DORNASE ALFA, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, CALCIUM, CETIRIZINE HYDROCHLORIDE, |
||||
| 338 | 26504575 |
CA |
25 | 2 |
Infection, Clostridium difficile infection, Opportunistic infection, Immunodeficiency, Nasopharyngitis, Pain, Crying, Product use issue, |
||||
ADALIMUMAB-BWWD, ADALIMUMAB-BWWD, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, HYDROXYCHLOROQUINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASCORBIC ACID, |
||||
| 339 | 26504675 |
21 | ||
Nasopharyngitis, Headache, Malaise, Toothache, Tooth extraction, Road traffic accident, Stress, Pain, Hidradenitis, Condition aggravated, Injection site pain, Insurance issue, Therapy interrupted, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 340 | 26504716 |
40 | ||
Nasopharyngitis, Illness, Inappropriate schedule of product administration, |
||||
BIMEKIZUMAB, |
||||
| 341 | 26505025 |
US |
2 | |
Speech disorder, Nasopharyngitis, |
||||
VIBEGRON, |
||||
| 342 | 26505051 |
CA |
65 | 2 |
Adjustment disorder, Affect lability, Angina pectoris, Anxiety, Aphasia, Arterial occlusive disease, Arthritis, Asthenia, Blood pressure increased, Carotid artery thrombosis, Cataract, Cerebrovascular accident, Chest discomfort, Confusional state, Coordination abnormal, Cough, Cystitis, Dysarthria, Dysphagia, Eating disorder, Fall, Fatigue, Gangrene, Gastrointestinal disorder, Headache, Hemiparesis, Hemiplegia, Influenza, Influenza like illness, Malaise, Motor dysfunction, Muscle spasticity, Muscular weakness, Nasopharyngitis, Nausea, Neurologic neglect syndrome, Pain, Palpitations, Personality disorder, Pneumonia, Product use issue, Psoriasis, Pyrexia, Respiratory tract congestion, Rheumatoid arthritis, Rhinorrhoea, Sensory loss, Sinus congestion, Sinus disorder, Sinusitis, Skin exfoliation, Skin haemorrhage, Sneezing, Vomiting, |
||||
RITUXIMAB, RITUXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACITRETIN, IRBESARTAN, COAL TAR, CYANOCOBALAMIN, DULOXETINE HYDROCHLORIDE, EZETIMIBE, INSULIN LISPRO, HYDROCHLOROTHIAZIDE, INSULIN GLARGINE, METHYLPREDNISOLONE, METHYLPREDNISOLONE ACETATE, ROSUVASTATIN, ROSUVASTATIN CALCIUM, USTEKINUMAB, LEVOTHYROXINE SODIUM, TELMISARTAN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 343 | 26505086 |
CA |
29 | 2 |
Blood cholesterol abnormal, White blood cell count abnormal, Abdominal discomfort, Diarrhoea, Rhinorrhoea, Nasopharyngitis, Headache, Arthritis, Pneumonia, Hepatic steatosis, Intentional dose omission, Intentional dose omission, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 344 | 26505132 |
US |
12 | 1 |
Nasopharyngitis, Tremor, Dizziness, Chest discomfort, Anxiety, |
||||
RITLECITINIB, |
||||
| 345 | 26505221 |
US |
58 | 2 |
Cough, Vomiting, Vaginal haemorrhage, Choking, Dysphagia, Swelling face, Pain in jaw, Ear pain, Dyspnoea, Axillary pain, Back pain, Nasopharyngitis, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, |
||||
| 346 | 26505229 |
US |
2 | |
Pain, Diarrhoea, Hypoaesthesia, Onychoclasis, Onychomycosis, Nasopharyngitis, |
||||
OSIMERTINIB, |
||||
| 347 | 26505827 |
US |
1 | |
Nasopharyngitis, Discomfort, |
||||
OMALIZUMAB, |
||||
| 348 | 26506116 |
US |
9 | 2 |
Respiratory tract infection, Nasopharyngitis, Blood pressure systolic increased, Inappropriate schedule of product administration, Blood pressure decreased, |
||||
HUMAN IMMUNOGLOBULIN G, ALGLUCOSIDASE ALFA, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, HEPARIN SODIUM, WATER, STERILE WATER, STERILE WATER FOR INJECTION, |
||||
| 349 | 26506125 |
|||
Malaise, Pain, Nasopharyngitis, Incorrect dose administered, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 350 | 26506531 |
US |
||
Nasopharyngitis, |
||||
| 351 | 26506539 |
CA |
59 | 2 |
Hallucination, auditory, Hallucination, Nasopharyngitis, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 352 | 26506542 |
40 | ||
Influenza, Product dose omission issue, Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 353 | 26506551 |
US |
39 | 2 |
Gestational hypertension, Pre-eclampsia, Eclampsia, Caesarean section, Placenta praevia, Nasopharyngitis, |
||||
BREXPIPRAZOLE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 354 | 26506867 |
US |
2 | |
Weight increased, Swelling, Nasopharyngitis, Illness, Gastrooesophageal reflux disease, Nausea, Decreased appetite, Abdominal pain lower, Flank pain, |
||||
VELAGLUCERASE ALFA, EPINEPHRINE, ADRENALINUM, STERILE WATER FOR INJECTION, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FOLIC ACID, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, DULOXETINE HYDROCHLORIDE, DULOXETINE, METHOTREXATE, METHOTREXATE SODIUM, LIDOCAINE, METHYLPREDNISOLONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, ONDANSETRON HYDROCHLORIDE, CELECOXIB, DICYCLOMINE HYDROCHLORIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, MOMETASONE FUROATE, ALBUTEROL SULFATE, BUDESONIDE, CYANOCOBALAMIN, MAGNESIUM OXIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, HYDROXYZINE HYDROCHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 355 | 26507525 |
GB |
||
Acetabulum fracture, Acute sinusitis, Tonsillitis, Drug ineffective, Nervous system disorder, Gastrointestinal disorder, Respiratory disorder, Mediastinal disorder, Spinal disorder, Oropharyngeal pain, Infection, Injection site reaction, Nasopharyngitis, Pyrexia, Hypersensitivity, Headache, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 356 | 26497958 |
CA |
56 | 1 |
Immunodeficiency, Nasopharyngitis, Rhinorrhoea, Oropharyngeal pain, Pain, Asthenia, Nasopharyngitis, Rhinorrhoea, Oropharyngeal pain, Pain, |
||||
RIBOCICLIB, |
||||
| 357 | 26498115 |
US |
||
Nasopharyngitis, |
||||
VEDOLIZUMAB, |
||||
| 358 | 26498399 |
GB |
2 | |
Sepsis, Lower respiratory tract infection, Burning sensation, Headache, Fatigue, COVID-19, Nasopharyngitis, Influenza, Norovirus infection, Malaise, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 359 | 26498530 |
US |
||
Nasopharyngitis, Nasal congestion, Vertigo, Migraine, Product dose omission issue, Drug ineffective, Cough, Dizziness, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, METOCLOPRAMIDE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MIRTAZAPINE, POLYETHYLENE GLYCOL 3350, DENOSUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, METHYLPREDNISOLONE, SERTRALINE HYDROCHLORIDE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, LORAZEPAM, ROSUVASTATIN CALCIUM, UMECLIDINIUM, ALBUTEROL SULFATE, FINASTERIDE, LEVALBUTEROL TARTRATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TRETINOIN, BENZONATATE, MELOXICAM, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, MINOXIDIL, ONDANSETRON HYDROCHLORIDE, DOCUSATE SODIUM, SENNOSIDES, DOCUSATE SODIUM AND SENNOSIDES, DOCUSATE SODIUM SENNOSIDES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUPROPION HYDROCHLORIDE, FLUTICASONE PROPIONATE, OXYGEN, 0XYGEN, |
||||
| 360 | 26498532 |
US |
||
Pulmonary congestion, Nasopharyngitis, Influenza, |
||||
TREPROSTINIL, TREPROSTINIL, BUSPIRONE HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MACITENTAN, OXYGEN, 0XYGEN, DAPAGLIFLOZIN, TORSEMIDE, |
||||
| 361 | 26498560 |
US |
||
Peripheral swelling, Nasopharyngitis, Dizziness, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, AMLODIPINE BESYLATE, FERROUS SULFATE, FERROUS SULFATE, ALLOPURINOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LISINOPRIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 362 | 26498646 |
US |
81 | 2 |
Inappropriate schedule of product administration, Allergic bronchitis, Nasopharyngitis, |
||||
INSULIN GLARGINE, INSULIN GLARGINE, |
||||
| 363 | 26498709 |
CA |
41 | 2 |
Lower respiratory tract infection, Nasopharyngitis, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, MESALAMINE, |
||||
| 364 | 26498851 |
CA |
39 | 2 |
Hepatic enzyme increased, Gastroenteritis viral, Nasopharyngitis, Drug ineffective, |
||||
GUSELKUMAB, GUSELKUMAB, |
||||
| 365 | 26499009 |
AR |
70 | 2 |
Gastrointestinal obstruction, Haemorrhoids, Nasopharyngitis, |
||||
ETANERCEPT, |
||||
| 366 | 26499211 |
US |
1 | |
Nasopharyngitis, Product dose omission issue, |
||||
| 367 | 26499333 |
2 | ||
Nasopharyngitis, Inflammation, Peripheral swelling, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 368 | 26499417 |
US |
1 | |
Eating disorder, Retching, Nasopharyngitis, Nausea, Ageusia, Dizziness, Pruritus, |
||||
TIOPRONIN, |
||||
| 369 | 26499678 |
CA |
59 | 2 |
Muscle strain, Vulvovaginal burning sensation, Vulvovaginal pain, Head injury, Contusion, Ligament sprain, Joint swelling, Fall, Burning sensation, Arthralgia, Pain in extremity, Gait disturbance, Hypokinesia, Arthritis, Bowel movement irregularity, Urinary tract infection, Migraine, Migraine, Electric shock sensation, Seasonal allergy, Nasal congestion, Abdominal distension, Insomnia, Musculoskeletal discomfort, Joint range of motion decreased, Peripheral swelling, Peripheral coldness, Vitreous floaters, Poor venous access, Alopecia, Groin pain, Mobility decreased, Vision blurred, Visual impairment, Joint stiffness, Abdominal discomfort, Pain in extremity, Nausea, Hypoaesthesia, Abdominal pain, Paraesthesia, Pain, Fatigue, Headache, Incorrect drug administration rate, Nasopharyngitis, Oropharyngeal pain, Secretion discharge, Mass, Influenza, Pain, Skin swelling, Respiratory tract congestion, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, SOTALOL HYDROCHLORIDE, PREGABALIN, METOPROLOL TARTRATE, METOPROLOL, COLCHICINE, BISOPROLOL FUMARATE, CANDESARTAN, NAPROXEN, NAPROXEN SODIUM, UBROGEPANT, UBROGEPANT, BACLOFEN, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 370 | 26499788 |
GB |
2 | |
Lower respiratory tract infection, Malaise, Nasopharyngitis, Influenza, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, |
||||
| 371 | 26499888 |
US |
1 | |
Parkinson^s disease, Hallucination, Nasopharyngitis, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 372 | 26500828 |
CA |
39 | |
Nasopharyngitis, Oropharyngeal pain, Pyrexia, Chest pain, Aphonia, Headache, Speech disorder, Abdominal pain, Gallbladder disorder, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 373 | 26501235 |
CA |
2 | |
Pneumonia, Nasopharyngitis, Lung disorder, Cough, |
||||
SECUKINUMAB, |
||||
| 374 | 26501289 |
US |
89 | 2 |
Pneumonia, Nasopharyngitis, Fatigue, Chest discomfort, |
||||
BOSENTAN, |
||||
| 375 | 26501297 |
CA |
1 | |
Lower respiratory tract infection, Nasopharyngitis, |
||||
ALBUTEROL SULFATE, |
||||
| 376 | 26501500 |
EU |
73 | 1 |
Pneumonia, Psychomotor hyperactivity, Nosocomial infection, Akinesia, Secretion discharge, Contraindicated product administered, Hypokinesia, Decubitus ulcer, Hyperkinesia, Weight decreased, Device issue, Asthenia, Incorrect dose administered, Dyskinesia, Dysarthria, Nasopharyngitis, General physical health deterioration, Underdose, Device use error, Somnolence, Psychomotor hyperactivity, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYCODONE, CANDESARTAN, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, PREGABALIN, BISOPROLOL FUMARATE, ROTIGOTINE, AMANTADINE, SIMVASTATIN, OXYCODONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SERTRALINE, PANTOPRAZOLE, DARIFENACIN HYDROBROMIDE, MIRTAZAPINE, AMLODIPINE, OXAZEPAM, MAGNESIUM, |
||||
| 377 | 26501510 |
CA |
43 | 2 |
Systemic lupus erythematosus, Maternal exposure during pregnancy, Nasopharyngitis, Musculoskeletal pain, Alopecia, Hypertension, Pemphigus, Pericarditis, Inflammation, Arthropathy, Lower respiratory tract infection, Wheezing, Fatigue, Hand deformity, Facet joint syndrome, Obesity, Helicobacter infection, Mobility decreased, Duodenal ulcer perforation, Live birth, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ERENUMAB-AOOE, ERENUMAB-AOOE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CANDESARTAN, CANDESARTAN, CANDESARTAN, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 378 | 26501564 |
US |
||
Fatigue, Nasopharyngitis, Hypersensitivity, Feeling abnormal, Dizziness, Headache, Throat irritation, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, METHOTREXATE, METHOTREXATE SODIUM, TADALAFIL, MACITENTAN, HYDROXYCHLOROQUINE, PREDNISONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LEUCOVORIN CALCIUM, |
||||
| 379 | 26501575 |
US |
||
Therapy non-responder, Nasopharyngitis, Nasal congestion, Oropharyngeal pain, |
||||
TREPROSTINIL, TREPROSTINIL, VITAMIN C, FUROSEMIDE, ERGOCALCIFEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, SODIUM BICARBONATE, SODIUM BICARBONATE INJECTION,, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OXYGEN, 0XYGEN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GUAIFENESIN, |
||||
| 380 | 26501576 |
US |
||
Nephrolithiasis, Urinary tract infection, Pain, Dysgeusia, Fatigue, Injection site pain, Pyrexia, Nasopharyngitis, Pulmonary congestion, Cough, Dyspnoea, Oropharyngeal pain, Injection site induration, Product dose omission issue, Inappropriate schedule of product administration, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, VITAMIN C, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SERTRALINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ROSUVASTATIN CALCIUM, LOSARTAN POTASSIUM, LOSARTAN, DIAZEPAM, ERGOCALCIFEROL, AMITRIPTYLINE HYDROCHLORIDE, EPLERENONE, GABAPENTIN, DIGOXIN, GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 381 | 26501609 |
US |
74 | 2 |
COVID-19, Herpes zoster, Stress, Nasopharyngitis, |
||||
| 382 | 26501618 |
US |
||
Nasopharyngitis, Cough, Headache, |
||||
TREPROSTINIL, TREPROSTINIL, LEVOTHYROXINE SODIUM, AMLODIPINE BESYLATE, IRBESARTAN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, RITUXIMAB, EMPAGLIFLOZIN, METOLAZONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, OXYGEN, 0XYGEN, FUROSEMIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 383 | 26501630 |
US |
||
Palmar erythema, Insomnia, Upper-airway cough syndrome, Nasopharyngitis, Foreign body in mouth, Hypotension, |
||||
TREPROSTINIL, TREPROSTINIL, EMPAGLIFLOZIN, PRAVASTATIN SODIUM, ERGOCALCIFEROL, ALBUTEROL SULFATE, MAGNESIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, BENZONATATE, OXYGEN, 0XYGEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, FUROSEMIDE, TREPROSTINIL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZITHROMYCIN DIHYDRATE, |
||||
| 384 | 26501639 |
US |
||
Bronchitis, Nasopharyngitis, Malaise, Cough, Throat irritation, Chest pain, Dyspnoea, Headache, |
||||
TREPROSTINIL, PRAVASTATIN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CYANOCOBALAMIN, ALBUTEROL SULFATE, ERGOCALCIFEROL, RISANKIZUMAB-RZAA, SILDENAFIL CITRATE, SILDENAFIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, MONTELUKAST SODIUM, MONTELUKAST, DAPAGLIFLOZIN, OXYGEN, 0XYGEN, |
||||
| 385 | 26501746 |
US |
2 | |
Hypersensitivity, Nasopharyngitis, Respiratory tract infection, Herpes zoster, Urinary tract infection, Immunoglobulins decreased, |
||||
OCRELIZUMAB, |
||||
| 386 | 26501936 |
CA |
44 | 2 |
Maternal exposure during pregnancy, Pemphigus, Pericarditis, Peripheral swelling, Rheumatoid arthritis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Synovitis, Systemic lupus erythematosus, Wound, Weight increased, Pruritus, Pyrexia, Rash, Sinusitis, Swelling, Treatment failure, Therapeutic product effect decreased, Product use issue, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint swelling, Lower respiratory tract infection, Muscle injury, Nasopharyngitis, Pain, Duodenal ulcer perforation, Intentional product use issue, Medication error, Off label use, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, PREDNISOLONE ACETATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, APREPITANT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CELECOXIB, CELECOXIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GOLIMUMAB, VITAMIN C, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, NAPROXEN, NAPROXEN SODIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE SODIUM PHOSPHATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PANTOPRAZOLE, SULFASALAZINE, SULFASALAZINE, LORAZEPAM, CAFFEINE, CYANOCOBALAMIN, ERGOCALCIFEROL, LISINOPRIL, LORAZEPAM, MAGNESIUM, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, |
||||
| 387 | 26502133 |
US |
36 | |
Breast cancer metastatic, Nasopharyngitis, |
||||
MIFEPRISTONE, |
||||
| 388 | 26502139 |
BR |
86 | |
Upper limb fracture, Foot fracture, Gait disturbance, Dysphonia, Nasopharyngitis, Product physical issue, Suspected counterfeit product, |
||||
EPLERENONE, EPLERENONE, EPLERENONE, EPLERENONE, EPLERENONE, EPLERENONE, EPLERENONE, EPLERENONE, |
||||
| 389 | 26502452 |
CA |
73 | 1 |
COVID-19, Condition aggravated, Hypersomnia, Fatigue, Nasopharyngitis, Viral infection, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, |
||||
| 390 | 26502602 |
54 | ||
Nasopharyngitis, |
||||
BIMEKIZUMAB, |
||||
| 391 | 26502671 |
|||
Nasopharyngitis, Therapeutic product effect delayed, Off label use, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 392 | 26497492 |
US |
68 | 1 |
Nasopharyngitis, |
||||
TIRZEPATIDE, |
||||
| 393 | 26497535 |
GB |
36 | 2 |
Lower respiratory tract infection, Nausea, Vomiting, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion, Headache, Influenza like illness, Inappropriate schedule of product administration, Influenza like illness, Somnolence, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 394 | 26497602 |
US |
64 | 2 |
Nasopharyngitis, Dysphonia, |
||||
DULAGLUTIDE, |
||||
| 395 | 26497670 |
US |
75 | 2 |
Nasopharyngitis, Urinary tract infection, |
||||
DULAGLUTIDE, |
||||
| 396 | 26497739 |
US |
35 | 1 |
Blood glucose increased, Nasopharyngitis, |
||||
INSULIN LISPRO, |
||||
| 397 | 26497847 |
US |
71 | 2 |
Nasopharyngitis, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, AMANTADINE HYDROCHLORIDE, ALPRAZOLAM, AMLODIPINE BESYLATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, GABAPENTIN, PRAVASTATIN SODIUM, SERTRALINE HYDROCHLORIDE, |
||||
| 398 | 26496756 |
US |
||
Dyspnoea, Nasopharyngitis, Influenza, Illness, Decreased immune responsiveness, Oropharyngeal pain, Upper-airway cough syndrome, Nasal congestion, Dry eye, Hypersomnia, Fatigue, Headache, Limb discomfort, Dizziness, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 399 | 26496827 |
US |
1 | |
Nasopharyngitis, |
||||
EVOLOCUMAB, INCLISIRAN, |
||||
| 400 | 26496852 |
US |
63 | 2 |
Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28